AP-1 drug
Evidence from:
primary |
all sources
No related entities found.
Mentioned in (5)
Papers in which this entity is mentioned.
- Tumour-wide RNA splicing aberrations generate actionable public neoantigens. (2025)
- Transient loss of Polycomb components induces an epigenetic cancer fate. (2024)
- Joint single-cell measurements of nuclear proteins and RNA in vivo. (2021)
- Simultaneous single cell measurements of intranuclear proteins and gene expression (2021)
- Recurrent somatic mutations in regulatory regions of human cancer genomes. (2015)
Merged raw entities (3)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| ap-1 | gene | 15 | 24 |
| ap-1 | drug | 6 | 7 |
| fos/jun | drug | — | — |